University of Montreal: UM171 Breaks Ground
July 01, 2025
July 01, 2025
MONTREAL, Quebec, July 1 -- The University of Montreal issued the following news release:
* * *
UM171 breaks new ground
Developed at UdeM, the molecule could soon be approved in Europe to treat blood cancers in patients without a compatible donor - a major step towards commercialization.
Just a few years ago, there was little hope for people suffering from hematological malignancies requiring stem cell transplants, such as acute leukemia and my . . .
* * *
UM171 breaks new ground
Developed at UdeM, the molecule could soon be approved in Europe to treat blood cancers in patients without a compatible donor - a major step towards commercialization.
Just a few years ago, there was little hope for people suffering from hematological malignancies requiring stem cell transplants, such as acute leukemia and my . . .